Barclays’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-64,636
Closed -$113K 5489
2025
Q1
$113K Sell
64,636
-31,611
-33% -$41.7K ﹤0.01% 4360
2024
Q4
$152K Buy
96,247
+11,770
+14% +$18.1K ﹤0.01% 4427
2024
Q3
$133K Buy
84,477
+62,549
+285% +$103K ﹤0.01% 4492
2024
Q2
$39.1K Buy
+21,928
New +$50.9K ﹤0.01% 4299
2023
Q3
Sell
-225
Closed -$331 4687
2023
Q2
$331 Buy
225
+220
+4,400% +$293 ﹤0.01% 4400
2023
Q1
$4 Buy
+5
New +$7 ﹤0.01% 5045
2021
Q4
Sell
-5
Closed 4638
2021
Q3
$0 Buy
+5
New +$37 ﹤0.01% 4960
2019
Q2
Sell
-1
Closed 7220
2019
Q1
$0 Hold
1
﹤0.01% 7276
2018
Q4
$0 Sell
1
-66
-99% -$1.09K ﹤0.01% 7283
2018
Q3
$2K Buy
67
+66
+6,600% +$2.17K ﹤0.01% 6960
2018
Q2
$0 Hold
1
﹤0.01% 7239
2018
Q1
$0 Hold
1
﹤0.01% 7299
2017
Q4
$0 Hold
1
﹤0.01% 7089
2017
Q3
$0 Sell
1
-413
-100% -$51.9K ﹤0.01% 7021
2017
Q2
$49K Buy
414
+55
+15% +$9.18K ﹤0.01% 5376
2017
Q1
$71K Sell
359
-27
-7% -$5.14K ﹤0.01% 5127
2016
Q4
$103K Buy
386
+327
+554% +$106K ﹤0.01% 4724
2016
Q3
$23K Sell
59
-3
-5% -$1.23K ﹤0.01% 5401
2016
Q2
$22K Buy
62
+6
+11% +$4.3K ﹤0.01% 5230
2016
Q1
$40K Sell
56
-4
-7% -$3.18K ﹤0.01% 4906
2015
Q4
$58K Sell
60
-125
-68% -$125K ﹤0.01% 4711
2015
Q3
$133K Buy
185
+89
+93% +$91.3K ﹤0.01% 4428
2015
Q2
$115K Buy
96
+87
+967% +$140K ﹤0.01% 4568
2015
Q1
$16K Sell
9
-17
-65% -$36.9K ﹤0.01% 5952
2014
Q4
$51K Sell
26
-21
-45% -$37.4K ﹤0.01% 5697
2014
Q3
$34K Sell
47
-40
-46% -$33.8K ﹤0.01% 6155
2014
Q2
$83K Buy
87
+20
+30% +$17.1K ﹤0.01% 5567
2014
Q1
$73K Buy
67
+65
+3,250% +$72K ﹤0.01% 5692
2013
Q4
$1K Sell
2
-1
-33% -$861 ﹤0.01% 7448
2013
Q3
$3K Sell
3
-52
-95% -$61.3K ﹤0.01% 7120
2013
Q2
$65K Buy
+55
New +$52.3K ﹤0.01% 6116

Other funds holding RGLS